Subros Limited
Momentum (62/100) does the heavy lifting; valuation (17/100) is the drag.
ExpensiveSubros Limited earns a Sell from StocksWizard, with a blended score of 44/100. At ₹819.25 it trades above our blended DCF and relative-multiples fair value of ₹615.08, about 25% downside to that estimate — we read it as overvalued by 25%. On 32.4x trailing earnings it sits pricier than the Consumer Cyclical median of about 27.7x. The price is about 31% below its 52-week high of ₹1,194.2 and 29% above the low of ₹635.25. Financial health scores 100/100, in the safe band on the Altman Z-score, with a Piotroski F-score of 3/9. The average analyst target of ₹943 implies about 15% upside across 3 analysts. It clears 7 of 13 investability checks, with durability 51, valuation 26 and momentum 62 on our 0–100 scales.
Analysis by Ankit Sharma · StocksWizard's own estimates from end-of-day public data — see how we calculate them. For information only, not investment advice.
With a 20% margin of safety, our buy-below price is ₹492.07.
Analyst views
1-year price
EOD · 2026-07-3152-week range
-31.40% from the 52-week high.
Price above both moving averages reads as an intact uptrend; below both, the trend is against you.
Verdict pillars
Sell44Piotroski F-score 3/9 — quality of earnings & balance sheet.
Our scores
Durability rewards strong, low-debt, profitable businesses; Valuation rewards stocks cheap vs their sector; Momentum rewards strong price trends.
Investability checklist
- Fail: ROE above 15%: 14.9%
- Pass: Low debt (D/E < 0.5): 0.06x
- Fail: Positive free cash flow
- Pass: Revenue growth > 10%: 16%
- Pass: Earnings growing: 7%
- Fail: Net margin ≥ 10%: 4.4%
- Pass: Current ratio > 1.5: 1.61
- Fail: Below our fair value
- Fail: Margin of safety ≥ 20%
- Pass: Above 200-day average
- Pass: Above 50-day average
- No data: Positive 1-year return
- Pass: Altman Z in safe zone: Z 6.13
- Fail: Piotroski ≥ 7: 3/9
Quarterly results
Annual financials
Shareholding
- Promoter74.6%
- Institutions11.5%
- Public & other13.9%
Promoter holding via insider stake; institutional via reported holdings.
Key fundamentals
Bull case vs bear case
Bull case
Strengths
- Lightly leveraged balance sheet.
- Financially solid — Altman Z 6.13.
Opportunities
- Revenue growing (16% YoY).
Bear case
Weaknesses
- Weak Piotroski score (3/9).
Threats
- Rich valuation versus sector peers.
- Trades ~25% above our estimated fair value.
About Subros Limited
Subros Limited manufactures thermal products for automotive and non-automotive applications in India, including compressors, condensers, heating and ventilation systems, tubes, hoses, and refrigeration equipment. Its product portfolio spans bus air conditioning, railway engine cabin cooling, commercial and residential air conditioning systems, transport refrigeration, truck cabin systems, and off-roader air conditioning. The company exports its products internationally.
Subros Limited — frequently asked questions
Is Subros Limited a buy, hold or sell?
StocksWizard currently rates Subros Limited (SUBROS) a Sell, based on a blended score of 44/100 across valuation, quality, momentum and price trend. This is our own model-based view, not investment advice.
What is Subros Limited's fair value?
Our blended DCF and relative-valuation model estimates Subros Limited's fair value at about ₹615.08, versus a current price of ₹819.25 — roughly 25% downside. On that basis the stock looks overvalued by 25%.
Is Subros Limited financially healthy?
Subros Limited scores 100/100 on our financial-health model, placing it in the safe band on the Altman Z-score, with a Piotroski F-score of 3/9.
How has Subros Limited's share price performed?
Subros Limited is up 7% over three months, and last traded at ₹819.25. Past performance doesn't predict future returns.
More in Consumer Cyclical
View allOur verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.